Logo

Accelerate Diagnostics

JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More

Exact Sciences CEO Kevin Conroy discussed the firm's pipeline and plans for 2020 and beyond, while NanoString CEO Brad Gray talked about the company's GeoMx digital spatial profiling technology, among other presentations Wednesday.

Accelerate Diagnostics Preliminary Q4 Revenues Rise 94 Percent

The firm cited continued delays in getting instruments set up and running in labs, leading to less generation of consumables revenues.

People in the News: Roland Diggelmann, Victor Esch, Scott Hutton, David Brunel, More

Accelerate Diagnostics Banking on New Outcomes Data, Experienced COO to Drive Sales Growth
Premium

New outcomes data shows that the firm's test can help clinicians optimize antibiotic prescribing, but investment analysts have had mixed reactions.

Luminex, Accelerate Diagnostics Downgraded by JP Morgan to Underweight

The investment bank adjusted its December 2020 price target for Luminex's stock to $21 and for Accelerate Diagnostics' stock to $16.

Dec 26, 2018

GenMark Fungal Blood Culture Test Clears FDA

Aug 23, 2018

Luminex Verigene MDx Panel Speeds Up AST, Reduces Cost, Study Finds
Premium

Jun 15, 2017

FDA Clearance for GenMark's ePlex Intensifies Competition in Highly Plexed MDx Test Market
Premium

Sep 16, 2016

Sepset Biosciences Developing Sepsis Test Based on Cellular Reprogramming Signature
Premium

Jul 22, 2016

Speed and Accuracy Top Considerations for Lab Directors in Choosing Sepsis Dx
Premium

Jul 13, 2016

Accelerate Diagnostics' Pathogen ID, Antimicrobial Susceptibility Platform Moves Closer to Market
Premium

Jul 11, 2016

Accelerate Diagnostics Submits Molecular, Phenotypic Detection Technologies for FDA Evaluation

Jan 29, 2016

District Court Dismisses Shareholders' Lawsuit Against Accelerate Diagnostics

Aug 3, 2015

Accelerate Dx Posts Increase in Q2 Revenues, Net Loss

Jul 1, 2015

Accelerate Dx Lands CE Mark for ID/AST System, Initiates Clinical Trial Enrollment

May 11, 2015

Accelerate Dx Q1 Revenues Flat; Plans Clinical Trial for FDA Submission of Microbiology Platform

Mar 23, 2015

Accelerate Dx Faces Fraud Allegations in Shareholders' Class Action Suit

Mar 16, 2015

Accelerate Diagnostics Achieves ISO Certification

Feb 27, 2015

Accelerate Diagnostics' 2014 Revenues Rise Sharply

Feb 23, 2015

Accelerate Dx, Denver Health Medical Center Awarded $5M for Microbial MDx Development

Jan 13, 2015

JP Morgan Healthcare Conference, Day Two: Thermo Fisher Scientific, Affymetrix, Danaher, Hologic, Genmark, Accelerate Diagnostics

Nov 4, 2014

Accelerate Dx, CDC Collaborate on Early Detection of Antibiotic-Resistant Pathogens

May 5, 2014

Accelerate Dx Q1 Revenues Slide 13 Percent

May 2, 2014

Accelerate Diagnostics Completes $45M Rights Offering

Apr 7, 2014

Accelerate Dx Begins $45M Rights Offering

Breaking News
The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.